Recurrent or metastatic nasopharyngeal carcinoma is an aggressive disease, and long-term survival with chemotherapy alone is ...
Dr. Marc S. Hoffmann reveals promising 6-year results from the SEQUOIA study on zanubrutinib for chronic lymphocytic leukemia ...
A study published in the Journal of Clinical Oncology confirms that one of the first Food and Drug Administration-approved ...
ImmunityBio says Anktiva plus BCG showed durable survival and bladder preservation at 36 months in BCG-unresponsive bladder ...
The current melanoma staging system does not always reflect actual survival outcomes. In some cases, patients with thick but ...
CULVER CITY, Calif.--(BUSINESS WIRE)--Immunotherapy innovator ImmunityBio, Inc. (NASDAQ: IBRX), today announced positive results from its QUILT 3.055 trial demonstrating long-term extended survival of ...
Background Malnutrition influences prognosis in patients with heart failure, but current nutritional evaluation methods are ...
A meta-analysis of more than 140,000 patients found men and women have similar survival rates during the first decade after undergoing coronary artery bypass grafting (CABG). Beyond 10 years, women ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback